Smith & Nephew plc vs Teradyne, Inc. — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Teradyne, Inc. trades at $375 (market cap $52.25B). The key difference: Teradyne, Inc. is far larger — about 4.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| SNN | TER | |
|---|---|---|
Market Cap | $12.64B | $52.25B |
Sector | Health | Technology |
52-Week High | $38.70 | $483.84 |
52-Week Low | $28.73 | $90.15 |
Enterprise Value | $15.41B | $52.08B |
Dividend Yield | 2.57% | 0.16% |
Trailing returns across standard periods
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →